Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

36%

4 trials in Phase 3/4

Results Transparency

90%

9 of 10 completed trials have results

Key Signals

9 with results

Enrollment Performance

Analytics

Phase 2
6(54.5%)
Phase 3
4(36.4%)
Phase 1
1(9.1%)
11Total
Phase 2(6)
Phase 3(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)